In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

04:12 EDT 26th April 2015 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 4,300+

Tuesday 21st April 2015

California Healthcare Institute Statement on AB 463

So-called “Pharmaceutical Cost Transparency Act” would stifle innovation, exclusively targets a sector providing life saving medicines The California Healthcare Institute (CHI), a non-profit representing more than 275 leading life sciences organizations, released the following statement by CHI President and CEO Sara Radcliffe regarding California S...

Two New Studies on Honokiol Extract Show Promise for Kidney and Bladder Cancers

SANTA ROSA, Calif., April 21, 2015 /PRNewswire/ -- The botanical extract honokiol, a biologically active molecule isolated from the bark of Magnolia spp., holds promise as an adjunct treatment for aggressive bladder and kidney cancers, as reported in two new studies. New research on honokiol in bladder cancer was presented at the American Association for Cancer Research (AACR) Annual Meeting ...

Biothera’s Imprime PGG Cancer Immunotherapy Drug Candidate Shows Potential to Enhance Efficacy of Immune Checkpoint Inhibitors

New Data on Imprime PGG’s Ability to Enhance Expression of PD-L1 on Tumor Cells Presented at the American Association for Cancer Research Annual Meeting A scientific poster presented today during a late-breaking session at the American Association for Cancer Research (AACR) annual meeting showed that Biothera’s Imprime PGG investigational cancer im...

TRADE NEWS: Agilent Technologies Introduces New Q-TOF Mass Spectrometry System

Enhanced Hardware and Software of Midrange Instrument Sets Standard for Routine Analyses Agilent Technologies Inc. (NYSE: A) today introduced the Agilent 6545 Q-TOF mass spectrometry system, designed to provide added sensitivity for routine analyses. The new midrange system includes advances in hardware and software that make it both m...

Atlas Medical Executive Leadership to Deliver Messages on Actionable Intelligence and the Practice of Coordinated Diagnostics at Executive War College 2015

Atlas Medical today announced the laboratory leadership topics of its Benefactor Session and Master Session presentations at the 20th Annual Executive War College (EWC) conference to be held at the Sheraton New Orleans, May 5-6, 2015 in New Orleans, LA. The healthcare industry commonly accepts that lab data makes up more than 70% of patients’ cl...

OPKO Announces Publication of ProtecT Study Using Kallikrein Biomarkers in 4Kscore Test

OPKO Health, Inc. (NYSE:OPK) today announced the online publication of a study entitled “Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study” in the Journal of the Nationa

New Nucleic Acid and Protein Purification System Helps Ensure Efficient, Reliable Purification

Advanced functionality designed to improve reproducibility, deliver high quality samples with less time and effort AACR2015 -- Low and medium-throughput laboratories now have an alternative to manual processes and spin-column methods for nucleic acid purification, thanks to a new automated system. Thermo Scientific KingFisher Duo Prime Nucleic Aci...

XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014

Contract Research Organization, XenoTech, plans move into new global headquarters and expansion of service offerings after experiencing sizable revenue growth in 2014 Lenexa, KS (PRWEB) April 21, 2015 Contract Research Organization XenoTech, LLC, a division of Sekisui, has announced plans to relocate into a new 41,500 ft2 facility. The planned move will double the size of XenoTech’s global hea...

BRCA Breakthroughs?

Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.

National Access Project for Cancer Testing Gains Momentum

Sanofi is the newest partner in Consortium offering Canadian patients testing for cancer tumor mutations Contextual Genomics, a molecular diagnostics company developing genomic based cancer tests, and the Personalized Medicine Initiative (PMI), an organization bringing molecular-based medicine to Canadians, are pleased to announce that Sanofi (EURONEXT...

Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology

JACKSONVILLE, Fla., April 21, 2015 /PRNewswire/ -- A new, cutting edge prostate cancer test is now available in the First Coast that promises to revolutionize the way prostate cancer is diagnosed.  Dr. Ali Kasraeian, fellowship-trained at the world-renowned Montsouris Institute in Paris, France, performed the first UroNav MRI-fusion guided prostate biopsy in the North Florida/South Georg...

Tosoh buys an Indian invitro diagnostics company

Biospectrum The move helps Tosoh to further strengthen its presence in the Indian market [Read more]

Metamark Announces Partnership with Highmark Blue Shield to Provide Access to Comprehensive Urology Diagnostics

Sophisticated diagnostic tests now reimbursed through Highmark Blue Shield Metamark announced today that it has signed an agreement with Highmark Blue Shield to provide its 5.2 million members with in-network access to Metamark’s comprehensive suite of urology specialized diagnostic offerings. The agreement covers Highmark Blue Shield members ...

SurModics to Webcast Second Quarter 2015 Earnings Conference Call on April 30

Webcast is Live at 4:00 p.m. (CT) SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its second quarter 2015 conference call on Thursday, April 30, at 4:00 p.m. CT (5:00 p.m. ET). The Company will issue an earning...

ArQule Announces Data Presentations with ARQ 087, Inhibitor of FGFR, at AACR

Key findings provide correlation between biomarkers and clinical responses ArQule, Inc. (Nasdaq:ARQL) today announced that data with ARQ 087, a potent FGFR (Fibroblast Growth Factor Receptor) inhibitor, will be presented today at the 2015 Annual Meeting of the American Association for Cancer Research (AACR). ARQ 087 is currently in a Phase 2 trial in ...

Castle Biosciences Hires Vice President of Marketing

Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment, today announced the appointment of Timothy Decker as Vice President of Marketing. Mr. Decker will oversee global marketing strategy and tactical programs at Castle Biosciences. He joins the Company with over 25 years of experience in the molecular diagnostic...

New Customized Fluid Transfer Service Simplifies the Biopharmaceutical Manufacturing Process

Turnkey solutions enable users to focus on the process, not the purchasing and assembly of fluid transfer systems INTERPHEX 2015--Today’s manufacturers searching to simplify their supply chains and sharpen their production capabilities can benefit from a new fluid transfer service specifically for aseptic biopharmaceutical production.

Next-Generation Single-Use Mixers Combine High-Performance with Optimized Ergonomics

Feedback from process engineers drives expansion of single-use range of clean, compact and manageable mixers INTERPHEX 2015 – A new range of single-use mixers provides biopharmaceutical manufacturers with improved ergonomics, an overhead, angled mixing design and a smaller footprint to maximize space and efficiency in downstream processing....

Medical University of Vienna Research Demonstrates Value of ANGLE plc’s ‘Blood Biopsy’ Technology

Poster presentation at AACR April 21 shows Parsortix™ system in capturing and analyzing mRNA of circulating tumor cells for ovarian and breast cancer ANGLE plc (AIM:AGL OTCQX:ANPCY), a UK-based medical diagnostics company with pioneering products for cancer diagnostics and fetal health, announce a poster presentation by researchers from the Medical ...

New Blast Freezers Offer Rapid Freezing of Critical Bioprocessing Samples

Versatile, easy to use blast freezer, quickly prepares products for short and long-term cold storage INTERPHEX 2015 – A new blast freezer provides researchers looking to accommodate a variety of vessels with a versatile and flexible sample preparation device for use prior to cold storage. The Thermo Scientific XBF40D blast freezer provides resea...

New Easy Scale-up Media Drives 170 Percent Greater Cell Culture Productivity by Day 14

Maximizes CHO cell growth and protein expression while reducing labor intensity INTERPHEX 2015-- Biotherapeutic manufacturers can turn to powerful new base media designed to address critical efficiency challenges in bioprocessing, ensuring higher titers and faster cell growth with lower resource input.

Biologics Safety Testing Market Worth $3,130.85 Million by 2019

DALLAS, April 21, 2015 /PRNewswire/ -- According to a new market research report "Biologics Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), & Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents) - Global Forecast to 2019", published by MarketsandMarkets, the global B...

Bina Technologies and AstraZeneca Announce Collaborative Agreement for Global Deployment of Bina’s Genomic Management Solution

AstraZeneca will use Bina’s Genomic Management Solution to accelerate the incorporation of genomic data into its drug development programs across three main therapeutic areas Bina Technologies, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and AstraZeneca (NYSE: AZN) today announced

Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case

LOS ANGELES, April 21, 2015 /PRNewswire/ -- Decision Diagnostics Corp. (OTC PINK: DECN), the manufacturer, quality plan administrator and the exclusive worldwide sales, service and regulatory processes agent for the popular GenStrip™ 50, the FDA-cleared Green Alternative Strip, specifically designed to work with the market leading Johnson & Johnson's LifeScan OneTouch Ultra family o...

Kineta, University of Groningen Present New, Positive Data for Dalazatide in ANCA Vasculitis, an Orphan Disease

Dalazatide demonstrates targeted activity in multi-organ autoimmune disease that spares general immune response Kineta, Inc., a biotechnology company focused on the development of immune modulating drugs for critical diseases, and researchers from the University of Groningen, Netherlands, announced new data from a study that showed dalazatide (formerly...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks